Not under the bridge, maybe under the tongue. According to MMPJoe Oralyn has been successfully reformulated, but it's on the back burner due to other, more pressing initiatives. I agree that it's a long shot, but Rapid Mist may reinvent itself, just like Generex.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links